Search

everythinglearnresearchcommunity

for

Search:↓

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Melatonin treatment helps improve skin health in postmenopausal rats.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Decreased IGF-1R expression may contribute to sacrococcygeal pilonidal sinus development.

Certain long non-coding RNAs in cashmere goats affect hair growth when treated with a specific growth factor.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Finasteride doesn't affect erections much, but may decrease libido in men.

OCT binds strongly to hair sheath cells and may affect skin and hair growth with fewer side effects than vitamin D3.

Hair loss affects women's self-esteem; treatments like minoxidil can help.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Hair loss in balding individuals is linked to changes in specific hair growth-related genes.

Removing the ATR gene in adult mice causes rapid aging and stem cell loss.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Human skin produces sex hormones like estrogen and testosterone, influenced by ARO and StAR, which may affect skin elasticity and hair growth.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

Hair growth-related cells need the enzyme SCD1 to help maintain the area that supports hair growth.